A randomized, double-blind, phase III study of Docetaxel and Ramucirumab versus Docetaxel and placebo in the treatment of stage IV non-small-cell lung cancer after disease progression after 1 previous platinum-based therapy (REVEL): treatment ration (Q46404783)
Jump to navigation
Jump to search
scientific article published on 31 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, phase III study of Docetaxel and Ramucirumab versus Docetaxel and placebo in the treatment of stage IV non-small-cell lung cancer after disease progression after 1 previous platinum-based therapy (REVEL): treatment ration |
scientific article published on 31 July 2012 |
Statements
1 reference
A randomized, double-blind, phase III study of Docetaxel and Ramucirumab versus Docetaxel and placebo in the treatment of stage IV non-small-cell lung cancer after disease progression after 1 previous platinum-based therapy (REVEL): treatment ration (English)
1 reference
Edward B Garon
1 reference
Dachuang Cao
1 reference
Ekaterine Alexandris
1 reference
William J John
1 reference
Sergey Yurasov
1 reference
Maurice Perol
1 reference
31 July 2012
1 reference
1 reference
13
1 reference
6
1 reference
505-509
1 reference